Home
News
Create
Screeners
Insights
Auro Laboratories
221.
90
+14.70
(+7.09%)
Market Cap
₹138.26 Cr
PE Ratio
70.24
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+7.09%
1M
-15.14%
6M
-18.31%
1Y
-4.04%
5Y
+134.44%
View Company Insights
Latest news about Auro Laboratories
Auro Laboratories Limited Schedules Board Meeting on February 05, 2026 for Q3FY26 Financial Results
2 hrs ago
Today
Auro Laboratories Limited has scheduled a board meeting for February 05, 2026, to consider and approve unaudited financial results for the quarter ended December 31, 2025, along with the Limited Review Report. The company has maintained trading window restrictions for designated persons and their immediate relatives, which will continue until 48 hours after the board meeting concludes. This notification complies with SEBI Regulation 29(1)(a) requirements and has been communicated to BSE Limited under security code 530233.
Auro Laboratories Secures WHO-GMP Certification for API Manufacturing Facility
Nov 13, 2025
Auro Laboratories Reports Quarterly Loss of Rs 71.58 Lakhs
Nov 13, 2025
Auro Laboratories Announces Key Management Changes and Auditor Appointments
Aug 23, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation